Content Library

Articles

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease; A Meta-analysis and matching-adjusted indirect comparison
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry
Building infrastructure for outcomes-based agreements in Canada: can administrative health data be used to support an outcomes-based agreement in oncology?
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
Adopting a portfolio of ultrasonic and advanced bipolar electrosurgery devices from a single manufacturer compared to currently used ultrasonic and advanced bipolar devices: a probabilistic budget impact analysis from a Spanish hospital perspective
PO206 Indirect Treatment Comparisons Of The Gene Therapy Etranacogene Dezaparvovec (CSL222) Vs. Extended Half-life Factor Ix Therapies For Severe Or Moderately Severe Haemophilia B
Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis
Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal Spray for Diabetic Gastroparesis (DGP)